Your browser doesn't support javascript.
loading
Inhibition of Intermedin (Adrenomedullin 2) Suppresses the Growth of Glioblastoma and Increases the Antitumor Activity of Temozolomide.
Huang, Luping; Wang, Denian; Feng, Zhongxue; Zhao, Huan; Xiao, Fei; Wei, Yong'gang; Zhang, Heng; Li, Hongyu; Kong, Lingmiao; Li, Min; Liu, Fei; Zhang, Haili; Zhang, Wei.
Afiliação
  • Huang L; Department of Critical Care Medicine, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center of Biotherapy, Sichuan, China.
  • Wang D; Department of Respiratory and Critical Care Medicine, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Sichuan, China.
  • Feng Z; Department of Critical Care Medicine, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center of Biotherapy, Sichuan, China.
  • Zhao H; Department of Critical Care Medicine, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center of Biotherapy, Sichuan, China.
  • Xiao F; Department of Intensive Care Unit of Gynecology and Obstetrics, West China Second University Hospital, Sichuan University, Sichuan, China.
  • Wei Y; Department of Liver Surgery, West China Hospital, Sichuan University, Sichuan, China.
  • Zhang H; Department of Neurosurgery, West China Hospital, Sichuan University, Sichuan, China.
  • Li H; Liver Transplantation Center, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
  • Kong L; Department of Critical Care Medicine, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center of Biotherapy, Sichuan, China.
  • Li M; Department of Critical Care Medicine, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center of Biotherapy, Sichuan, China.
  • Liu F; Department of Liver Surgery, West China Hospital, Sichuan University, Sichuan, China.
  • Zhang H; Department of Liver Surgery, West China Hospital, Sichuan University, Sichuan, China.
  • Zhang W; Department of Critical Care Medicine, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center of Biotherapy, Sichuan, China. zhangwei197610@163.com.
Mol Cancer Ther ; 20(2): 284-295, 2021 02.
Article em En | MEDLINE | ID: mdl-33298587

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Glioblastoma / Adrenomedulina / Temozolomida Limite: Animals / Female / Humans Idioma: En Revista: Mol Cancer Ther Assunto da revista: ANTINEOPLASICOS Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Glioblastoma / Adrenomedulina / Temozolomida Limite: Animals / Female / Humans Idioma: En Revista: Mol Cancer Ther Assunto da revista: ANTINEOPLASICOS Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China País de publicação: Estados Unidos